Loading [Contrib]/a11y/accessibility-menu.js
JHSS
  • Menu
  • Articles
    • Original article
    • Review paper
    • All
  • For Authors
  • Editorial Board
  • About
  • Issues
  • search

    Sorry, something went wrong. Please try your search again.
    ×

    • Articles
    • Blog posts

RSS Feed

Enter the URL below into your favorite RSS reader.

https://jhss.scholasticahq.com/feed
×
Review paper
March 17, 2022 CDT

Immunotherapy using CRISPR-Cas9 systems to treat rheumatoid arthritis with PTPN22 R620W mutations and target PD-1 and CD20

Aishwarya Shivaraman , Nicole Guilz ,
  • Immunotherapy
  • Rheumatoid arthritis
  • PTPN22
  • T cells
  • B cells
  • CRISPR/Cas9
  • PDCD1
  • PD-1
  • MS4A1
  • CD20
ccby-nc-sa-4.0
JHSS
Shivaraman, Aishwarya, and Nicole Guilz. 2022. “Immunotherapy Using CRISPR-Cas9 Systems to Treat Rheumatoid Arthritis with PTPN22 R620W Mutations and Target PD-1 and CD20.” Journal of High School Science, March.
Save article as...▾
  • PDF
  • XML
  • Citation (BibTeX)
Powered by Scholastica, the modern academic journal management system